DANCO LABS LLC
PharmaDANCO LABS LLC is a pharmaceutical company focused on Metabolic.
DANCO LABS LLC's Key Drugs
DANCO LABS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
DANCO LABS LLC's Recent FDA Approvals
New NDA/BLA approvals for DANCO LABS LLC over the last two years — novel drugs only, excluding generics and label supplements.
DANCO LABS LLC's Therapeutic Areas
DANCO LABS LLC's approved drugs and pipeline span 1 therapeutic area, led by Metabolic, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
DANCO LABS LLC's Top Competitors
DANCO LABS LLC's closest competitors by therapeutic-area and drug-target overlap include Merck, Baxter, and Johnson & Johnson. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
DANCO LABS LLC Pipeline Snapshot
Active clinical trials for DANCO LABS LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Metabolic pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2000-09-28
- Latest
- 2025-09-30
- Applications
- 1